Karen S Pavur

Title: The Innovative Contributions of Karen S. Pavur

Introduction

Karen S. Pavur is a distinguished inventor based in Highland Park, NJ (US). She has made significant contributions to the field of biochemistry, particularly in the study of protein kinases. Her work has implications for understanding tumor growth and other hyperproliferative disorders.

Latest Patents

Karen S. Pavur holds a patent for her invention titled "Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor." This patent describes a new superfamily of protein kinases centered around eukaryotic elongation factor-2 kinase (eEF-2 kinase). The characteristics of this superfamily include sequence similarity to eEF-2 kinase, a lack of sequence similarity to other known protein kinase superfamilies, and the ability to specifically phosphorylate α-helical regions of proteins. This discovery has led to the development of assays utilizing eEF-2 kinase and a novel α-helical 16-amino acid peptide sequence for high-throughput screening of compounds that can inhibit this protein kinase. The invention also includes methods for assessing eEF-2 kinase levels for diagnostic purposes and therapeutic formulations to inhibit its activity.

Career Highlights

Karen is affiliated with the University of Medicine and Dentistry of New Jersey, where she continues her research and innovation in the field of biochemistry. Her work has garnered attention for its potential applications in cancer treatment and other medical fields.

Collaborations

Throughout her career, Karen has collaborated with notable colleagues, including William N. Hait and Alexey Ryazanov. These collaborations have furthered her research and contributed to the advancement of knowledge in her area of expertise.

Conclusion

Karen S. Pavur's innovative work in the field of protein kinases has the potential to impact medical science significantly. Her contributions are paving the way for new diagnostic and therapeutic approaches in treating hyperproliferative disorders.